Inducible T-Cell Co-Stimulator Ligand
"Inducible T-Cell Co-Stimulator Ligand" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A B7 antigen that binds specifically to INDUCIBLE T-CELL CO-STIMULATOR PROTEIN on T-CELLS. It provides a costimulatory signal for T-cell proliferation and cytokine secretion.
| Descriptor ID |
D060945
|
| MeSH Number(s) |
D12.776.467.150.500 D12.776.543.095.500 D23.050.301.285.500 D23.529.168.500
|
| Concept/Terms |
Inducible T-Cell Co-Stimulator Ligand- Inducible T-Cell Co-Stimulator Ligand
- Inducible T Cell Co Stimulator Ligand
- CD275 Antigen
- Antigen, CD275
- Antigens, CD275
- CD275 Antigens
- B7-Related Protein-1
- B7H2 Antigen
- Antigen, B7H2
- B7-H2 Antigen
- Antigen, B7-H2
- B7 H2 Antigen
- B7-H2 Ligand
- B7 H2 Ligand
- Ligand, B7-H2
- B7-Like Protein Gl50
- B7 Like Protein Gl50
- Protein Gl50, B7-Like
- B7-Related Protein 1
- B7 Related Protein 1
|
Below are MeSH descriptors whose meaning is more general than "Inducible T-Cell Co-Stimulator Ligand".
Below are MeSH descriptors whose meaning is more specific than "Inducible T-Cell Co-Stimulator Ligand".
This graph shows the total number of publications written about "Inducible T-Cell Co-Stimulator Ligand" by people in this website by year, and whether "Inducible T-Cell Co-Stimulator Ligand" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Inducible T-Cell Co-Stimulator Ligand" by people in Profiles.
-
[Loss of human ICOSLG results in combined immunodeficiency]. Med Sci (Paris). 2019 Aug-Sep; 35(8-9):625-628.
-
Loss of human ICOSL results in combined immunodeficiency. J Exp Med. 2018 12 03; 215(12):3151-3164.
-
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis. Arthritis Rheumatol. 2018 07; 70(7):1071-1076.